Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karolina Michalska is active.

Publication


Featured researches published by Karolina Michalska.


FEBS Journal | 2013

Structural and functional aspects of PR-10 proteins

Humberto Fernandes; Karolina Michalska; Michal Sikorski; Mariusz Jaskolski

Physical, chemical and biological stress factors, such as microbial infection, upregulate the transcription levels of a number of plant genes, coding for the so‐called pathogenesis‐related (PR) proteins. For PR proteins of class‐10 (PR‐10), the biological function remains unclear, despite two decades of scientific research. PR‐10 proteins have a wide distribution throughout the plant kingdom and the class members share size and secondary structure organization. Throughout the years, we and other groups have determined the structures of a number of PR‐10 proteins, both in the crystalline state by X‐ray diffraction and in solution by NMR spectroscopy. Despite the accumulating structural information, our understanding of PR‐10 function is still limited. PR‐10 proteins are rather small (~ 160 amino acids) with a fold consisting of three α helices and seven antiparallel β strands. These structural elements enclose a large hydrophobic cavity that is most probably the key to their functional relevance. Also, the outer surface of these proteins is of extreme interest, as epitopes from a PR‐10 subclass cause allergic reactions in humans.


FEBS Journal | 2010

Crystal structure of human cystatin C stabilized against amyloid formation

Robert Kolodziejczyk; Karolina Michalska; Alejandra Hernández-Santoyo; Maria Wahlbom; Anders Grubb; Mariusz Jaskolski

Human cystatin C (HCC) is a family 2 cystatin inhibitor of papain‐like (C1) and legumain‐related (C13) cysteine proteases. In pathophysiological processes, the nature of which is not understood, HCC is codeposited in the amyloid plaques of Alzheimer’s disease or Down’s syndrome. The amyloidogenic properties of HCC are greatly increased in a naturally occurring L68Q variant, resulting in fatal cerebral amyloid angiopathy in early adult life. In all crystal structures of cystatin C studied to date, the protein has been found to form 3D domain‐swapped dimers, created through a conformational change of a β‐hairpin loop, L1, from the papain‐binding epitope. We have created monomer‐stabilized human cystatin C, with an engineered disulfide bond (L47C)–(G69C) between the structural elements that become separated upon domain swapping. The mutant has drastically reduced dimerization and fibril formation properties, but its inhibition of papain is unaltered. The structure confirms the success of the protein engineering experiment to abolish 3D domain swapping and, in consequence, amyloid fibril formation. It illustrates for the first time the fold of monomeric cystatin C and allows verification of earlier predictions based on the domain‐swapped forms and on the structure of chicken cystatin. Importantly, the structure defines the so‐far unknown conformation of loop L1, which is essential for the inhibition of papain‐like cysteine proteases.


Journal of Biological Chemistry | 2008

The mechanism of autocatalytic activation of plant-type L-asparaginases.

Karolina Michalska; Alejandra Hernández-Santoyo; Mariusz Jaskolski

Plant l-asparaginases and their bacterial homologs, such as EcAIII found in Escherichia coli, form a subgroup of the N-terminal nucleophile (Ntn)-hydrolase family. In common with all Ntn-hydrolases, they are expressed as inactive precursors that undergo activation in an autocatalytic manner. The maturation process involves intramolecular hydrolysis of a single peptide bond, leading to the formation of two subunits (α and β) folded as one structural domain, with the nucleophilic Thr residue located at the freed N terminus of subunit β. The mechanism of the autocleavage reaction remains obscure. We have determined the crystal structure of an active site mutant of EcAIII, with the catalytic Thr residue substituted by Ala (T179A). The modification has led to a correctly folded but unprocessed molecule, revealing the geometry and molecular environment of the scissile peptide bond. The autocatalytic reaction is analyzed from the point of view of the Thr179 side chain rotation, identification of a potential general base residue, and the architecture of the oxyanion hole.


Journal of Structural Biology | 2010

Crystal structure of Hyp-1, a St. John's wort protein implicated in the biosynthesis of hypericin.

Karolina Michalska; Humberto Fernandes; Michal Sikorski; Mariusz Jaskolski

Hypericin, a red-colored naphtodianthrone, is a natural product synthesized in the medicinal plant Hypericum perforatum, widely known as St. Johns wort. Hypericin has been attracting a growing attention of the pharmaceutical industry because of its potential application in various therapies, including the treatment of depression. In vivo, hypericin is synthesized by dimerization of emodin in a complicated multistep reaction that is reportedly catalyzed by a small (17.8kDa) protein, Hyp-1. Based on relatively low sequence similarity ( approximately 50%), Hyp-1 has been tentatively classified as a plant PR-10 (pathogenesis-related class 10) protein. Members of the PR-10 family are ubiquitous plant proteins associated with stress control and tissue differentiation but with no clearly understood molecular mechanism. They have, however, a well-defined folding canon, consisting of an extended antiparallel beta-sheet wrapped around a C-terminal alpha-helix, enclosing in the protein interior a huge cavity, in which various hydrophobic ligands can be bound. Apart from Hyp-1, only two other PR-10 members have been found to possess enzymatic activity (S-norcoclaurine synthase and TcmN aromatase/cyclase). In this paper, we report a high-resolution crystal structure of Hyp-1, confirming that it indeed has a PR-10 fold. The protein binds multiple polyethylene glycol molecules, some of which occupy the hydrophobic cavity. The crystallographic model illustrates a high degree of conformational adaptability of both interacting partners for efficient binding. We have been unable, however, to dimerize emodin to hypericin using Hyp-1 as biocatalyst. This puzzling result does not have a clear explanation at this time.


Nature Chemical Biology | 2017

A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase.

Samantha Wellington; Partha Nag; Karolina Michalska; Stephen Johnston; Robert Jedrzejczak; Virendar K. Kaushik; Anne E. Clatworthy; Noman Siddiqi; Patrick McCarren; Besnik Bajrami; Natalia Maltseva; Senya Combs; Stewart L. Fisher; Andrzej Joachimiak; Stuart L. Schreiber; Deborah T. Hung

New antibiotics with novel targets are greatly needed. Bacteria have numerous essential functions, but only a small fraction of such processes-primarily those involved in macromolecular synthesis-are inhibited by current drugs. Targeting metabolic enzymes has been the focus of recent interest, but effective inhibitors have been difficult to identify. We describe a synthetic azetidine derivative, BRD4592, that kills Mycobacterium tuberculosis (Mtb) through allosteric inhibition of tryptophan synthase (TrpAB), a previously untargeted, highly allosterically regulated enzyme. BRD4592 binds at the TrpAB α-β-subunit interface and affects multiple steps in the enzymes overall reaction, resulting in inhibition not easily overcome by changes in metabolic environment. We show that TrpAB is required for the survival of Mtb and Mycobacterium marinum in vivo and that this requirement may be independent of an adaptive immune response. This work highlights the effectiveness of allosteric inhibition for targeting proteins that are naturally highly dynamic and that are essential in vivo, despite their apparent dispensability under in vitro conditions, and suggests a framework for the discovery of a next generation of allosteric inhibitors.


Molecular Systems Biology | 2016

Diverse mechanisms of metaeffector activity in an intracellular bacterial pathogen, Legionella pneumophila

Malene L. Urbanus; Andrew T. Quaile; Peter J. Stogios; Mariya Morar; Chitong Rao; Rosa Di Leo; Elena Evdokimova; Mandy H. Y. Lam; Christina Oatway; Marianne E. Cuff; Jerzy Osipiuk; Karolina Michalska; Boguslaw Nocek; Mikko Taipale; Alexei Savchenko; Alexander W. Ensminger

Pathogens deliver complex arsenals of translocated effector proteins to host cells during infection, but the extent to which these proteins are regulated once inside the eukaryotic cell remains poorly defined. Among all bacterial pathogens, Legionella pneumophila maintains the largest known set of translocated substrates, delivering over 300 proteins to the host cell via its Type IVB, Icm/Dot translocation system. Backed by a few notable examples of effector–effector regulation in L. pneumophila, we sought to define the extent of this phenomenon through a systematic analysis of effector–effector functional interaction. We used Saccharomyces cerevisiae, an established proxy for the eukaryotic host, to query > 108,000 pairwise genetic interactions between two compatible expression libraries of ~330 L. pneumophila‐translocated substrates. While capturing all known examples of effector–effector suppression, we identify fourteen novel translocated substrates that suppress the activity of other bacterial effectors and one pair with synergistic activities. In at least nine instances, this regulation is direct—a hallmark of an emerging class of proteins called metaeffectors, or “effectors of effectors”. Through detailed structural and functional analysis, we show that metaeffector activity derives from a diverse range of mechanisms, shapes evolution, and can be used to reveal important aspects of each cognate effectors function. Metaeffectors, along with other, indirect, forms of effector–effector modulation, may be a common feature of many intracellular pathogens—with unrealized potential to inform our understanding of how pathogens regulate their interactions with the host cell.


Proteins | 2011

Target highlights in CASP9: Experimental target structures for the critical assessment of techniques for protein structure prediction.

Andriy Kryshtafovych; John Moult; Sergio G. Bartual; J. Fernando Bazan; Helen M. Berman; Darren E. Casteel; Evangelos Christodoulou; John K. Everett; Jens Hausmann; Tatjana Heidebrecht; Tanya Hills; Raymond Hui; John F. Hunt; Jayaraman Seetharaman; Andrzej Joachimiak; Michael A. Kennedy; Choel Kim; Andreas Lingel; Karolina Michalska; Gaetano T. Montelione; José M. Otero; Anastassis Perrakis; Juan C. Pizarro; Mark J. van Raaij; Theresa A. Ramelot; Francois Rousseau; Liang Tong; Amy K. Wernimont; Jasmine Young; Torsten Schwede

One goal of the CASP community wide experiment on the critical assessment of techniques for protein structure prediction is to identify the current state of the art in protein structure prediction and modeling. A fundamental principle of CASP is blind prediction on a set of relevant protein targets, that is, the participating computational methods are tested on a common set of experimental target proteins, for which the experimental structures are not known at the time of modeling. Therefore, the CASP experiment would not have been possible without broad support of the experimental protein structural biology community. In this article, several experimental groups discuss the structures of the proteins which they provided as prediction targets for CASP9, highlighting structural and functional peculiarities of these structures: the long tail fiber protein gp37 from bacteriophage T4, the cyclic GMP‐dependent protein kinase Iβ dimerization/docking domain, the ectodomain of the JTB (jumping translocation breakpoint) transmembrane receptor, Autotaxin in complex with an inhibitor, the DNA‐binding J‐binding protein 1 domain essential for biosynthesis and maintenance of DNA base‐J (β‐D‐glucosyl‐hydroxymethyluracil) in Trypanosoma and Leishmania, an so far uncharacterized 73 residue domain from Ruminococcus gnavus with a fold typical for PDZ‐like domains, a domain from the phycobilisome core‐membrane linker phycobiliprotein ApcE from Synechocystis, the heat shock protein 90 activators PFC0360w and PFC0270w from Plasmodium falciparum, and 2‐oxo‐3‐deoxygalactonate kinase from Klebsiella pneumoniae. Proteins 2011;


Journal of Molecular Biology | 2012

Characterization of Transport Proteins for Aromatic Compounds Derived from Lignin: Benzoate Derivative Binding Proteins

Karolina Michalska; Changsoo Chang; Jamey Mack; Sarah Zerbs; Andrzej Joachimiak; Frank R. Collart

In vitro growth experiments have demonstrated that aromatic compounds derived from lignin can be metabolized and represent a major carbon resource for many soil bacteria. However, the proteins that mediate the movement of these metabolites across the cell membrane have not been thoroughly characterized. To address this deficiency, we used a library representative of lignin degradation products and a thermal stability screen to determine ligand specificity for a set of solute-binding proteins (SBPs) from ATP-binding cassette (ABC) transporters. The ligand mapping process identified a set of proteins from Alphaproteobacteria that recognize various benzoate derivatives. Seven high-resolution crystal structures of these proteins in complex with four different aromatic compounds were obtained. The protein-ligand complexes provide details of molecular recognition that can be used to infer binding specificity. This structure-function characterization provides new insight for the biological roles of these ABC transporters and their SBPs, which had been previously annotated as branched-chain amino-acid-binding proteins. The knowledge derived from the crystal structures provides a foundation for development of sequence-based methods to predict the ligand specificity of other uncharacterized transporters. These results also demonstrate that Alphaproteobacteria possess a diverse set of transport capabilities for lignin-derived compounds. Characterization of this new class of transporters improves genomic annotation projects and provides insight into the metabolic potential of soil bacteria.


Acta Crystallographica Section D-biological Crystallography | 2008

Crystal packing of plant-type L-asparaginase from Escherichia coli.

Karolina Michalska; Dominika Borek; Alejadra Hernández‐Santoyo; Mariusz Jaskolski

Plant-type L-asparaginases hydrolyze the side-chain amide bond of L-asparagine or its beta-peptides. They belong to the N-terminal nucleophile (Ntn) hydrolases and are synthesized as inactive precursor molecules. Activation occurs via the autoproteolytic release of two subunits, alpha and beta, the latter of which carries the nucleophile at its N-terminus. Crystallographic studies of plant-type asparaginases have focused on an Escherichia coli homologue (EcAIII), which has been crystallized in several crystal forms. Although they all belong to the same P2 1 2 1 2 1 space group with similar unit-cell parameters, they display different crystal-packing arrangements and thus should be classified as separate polymorphs. This variability stems mainly from different positions of the EcAIII molecules within the unit cell, although they also exhibit slight differences in orientation. The intermolecular interactions that trigger different crystal lattice formation are mediated by ions, which represent the most variable component of the crystallization conditions. This behaviour confirms recent observations that small molecules might promote protein crystal lattice formation.


Acta Crystallographica Section D-biological Crystallography | 2013

GH1-family 6-P-β-glucosidases from human microbiome lactic acid bacteria

Karolina Michalska; Kemin Tan; Hui Li; Catherine Hatzos-Skintges; Jessica Bearden; Gyorgy Babnigg; Andrzej Joachimiak

The crystal structures of two 6-P-β-glucosidases from the GH1 family were determined in the apo form and in the presence of a 6′-P-salicin substrate, of the reaction product 6-P-β-glucose and of glucose corresponding to the aglycon molecule. The presence of natural ligands enabled the definition of the structural elements responsible for the recognition and hydrolysis of 6′-P-β-glucosides.

Collaboration


Dive into the Karolina Michalska's collaboration.

Top Co-Authors

Avatar

Andrzej Joachimiak

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Mariusz Jaskolski

Polish Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Gyorgy Babnigg

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Robert Jedrzejczak

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Changsoo Chang

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Hui Li

University of Chicago

View shared research outputs
Top Co-Authors

Avatar

Michael Endres

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lance Bigelow

Argonne National Laboratory

View shared research outputs
Researchain Logo
Decentralizing Knowledge